Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0000899243-18-031719

Director acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Martin Robert Daniel Director 2018-12-20 Grant or award +60,000 $0.08 $4,800 116,000 D
Loading xslF345X03/doc4.xml…